150 related articles for article (PubMed ID: 20015875)
1. Early hemorrhagic death before starting therapy in acute promyelocytic leukemia: association with high WBC count, late diagnosis and delayed treatment initiation.
Breccia M; Latagliata R; Cannella L; Minotti C; Meloni G; Lo-Coco F
Haematologica; 2010 May; 95(5):853-4. PubMed ID: 20015875
[No Abstract] [Full Text] [Related]
2. Update on the management of pediatric acute promyelocytic leukemia.
Feusner J; Gregory JJ
Clin Adv Hematol Oncol; 2006 Nov; 4(11):854-5; author reply 855-6. PubMed ID: 17193721
[No Abstract] [Full Text] [Related]
3. Thrombo-hemorrhagic deaths in acute promyelocytic leukemia.
Breccia M; Lo Coco F
Thromb Res; 2014 May; 133 Suppl 2():S112-6. PubMed ID: 24862130
[TBL] [Abstract][Full Text] [Related]
4. Update on the management of pediatric acute promyelocytic leukemia.
Ribeiro R
Clin Adv Hematol Oncol; 2006 Apr; 4(4):263-5. PubMed ID: 16728936
[No Abstract] [Full Text] [Related]
5. Risk Markers for Significant Bleeding and Thrombosis in Pediatric Acute Promyelocytic Leukemia; Report From the Children's Oncology Group Study AAML0631.
Rajpurkar M; Alonzo TA; Wang YC; Gerbing RB; Gamis AS; Feusner JH; Gregory J; Kutny MA
J Pediatr Hematol Oncol; 2019 Jan; 41(1):51-55. PubMed ID: 30095694
[TBL] [Abstract][Full Text] [Related]
6. Predictors of early death, serious hemorrhage, and differentiation syndrome in Japanese patients with acute promyelocytic leukemia.
Minamiguchi H; Fujita H; Atsuta Y; Asou N; Sakura T; Ueda Y; Sawa M; Dobashi N; Taniguchi Y; Suzuki R; Uchino Y; Tomita A; Tamaki S; Hagihara M; Fujimaki K; Yanada M; Maeda Y; Iwanaga M; Usui N; Kobayashi Y; Ohtake S; Kiyoi H; Matsumura I; Miyazaki Y; Naoe T; Takeshita A;
Ann Hematol; 2020 Dec; 99(12):2787-2800. PubMed ID: 32879992
[TBL] [Abstract][Full Text] [Related]
7. Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction.
Hambley BC; Norsworthy KJ; Jasem J; Zimmerman JW; Shenderov E; Webster JA; Showel MM; Gondek LP; Dalton WB; Prince G; Gladstone DE; Streiff MB; Pratz KW; Gojo I; Ghiaur G; Levis MJ; Smith BD; DeZern AE
Leuk Res; 2019 Aug; 83():106174. PubMed ID: 31255938
[No Abstract] [Full Text] [Related]
8. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
[TBL] [Abstract][Full Text] [Related]
9. Predictors of early hemorrhage in acute promyelocytic leukemia.
Naymagon L; Moshier E; Tremblay D; Mascarenhas J
Leuk Lymphoma; 2019 Oct; 60(10):2394-2403. PubMed ID: 30849255
[TBL] [Abstract][Full Text] [Related]
10. Analysis of early death in newly diagnosed acute promyelocytic leukemia patients.
Xu F; Wang C; Yin C; Jiang X; Jiang L; Wang Z; Meng F
Medicine (Baltimore); 2017 Dec; 96(51):e9324. PubMed ID: 29390508
[TBL] [Abstract][Full Text] [Related]
11. Short-term treatment for adult hypergranular and microgranular acute promyelocytic leukemia.
Bassan R; Battista R; Viero P; d'Emilio A; Buelli M; Montaldi A; Rambaldi A; Tremul L; Dini E; Barbui T
Leukemia; 1995 Feb; 9(2):238-43. PubMed ID: 7869758
[TBL] [Abstract][Full Text] [Related]
12. Causes and prognostic factors for early death in patients with acute promyelocytic leukemia treated with single-agent arsenic trioxide.
Hou J; Wang S; Zhang Y; Fan D; Li H; Yang Y; Ge F; Hou W; Fu J; Wang P; Zhao H; Sun J; Yang K; Zhou J; Li X
Ann Hematol; 2017 Dec; 96(12):2005-2013. PubMed ID: 28940056
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors in acute promyelocytic leukemia: strategies to define high-risk patients.
Testa U; Lo-Coco F
Ann Hematol; 2016 Apr; 95(5):673-80. PubMed ID: 26920716
[TBL] [Abstract][Full Text] [Related]
14. Difference in causes and prognostic factors of early death between cohorts with de novo and relapsed acute promyelocytic leukemia.
Zhao H; Zhao Y; Zhang Y; Hou J; Yang H; Cao F; Yang Y; Hou W; Sun J; Jin B; Fu J; Li H; Wang P; Ge F; Zhou J
Ann Hematol; 2018 Mar; 97(3):409-416. PubMed ID: 29289982
[TBL] [Abstract][Full Text] [Related]
15. Improved outcome of acute promyelocytic leukemia with high WBC counts over the last 15 years: the European APL Group experience.
Kelaidi C; Chevret S; De Botton S; Raffoux E; Guerci A; Thomas X; Pigneux A; Lamy T; Rigal-Huguet F; Meyer-Monard S; Chevallier P; Maloisel F; Deconinck E; Ferrant A; Fegueux N; Ifrah N; Sanz M; Dombret H; Fenaux P; Adès L
J Clin Oncol; 2009 Jun; 27(16):2668-76. PubMed ID: 19414681
[TBL] [Abstract][Full Text] [Related]
16. B & B: basophils and bleeding, an atypical case of acute promyelocytic leukemia.
Lebecque B; Lechevalier N
Blood; 2018 Nov; 132(19):2107. PubMed ID: 30409896
[No Abstract] [Full Text] [Related]
17. Effect of initial absolute monocyte count on survival outcome of patients with de novo non-M3 acute myeloid leukemia.
Feng J; Zhang W; Wu J; Gao S; Ye H; Sun L; Chen Y; Yu K; Xing CY
Leuk Lymphoma; 2016 Nov; 57(11):2548-54. PubMed ID: 27074049
[TBL] [Abstract][Full Text] [Related]
18. Administration of ATRA to newly diagnosed patients with acute promyelocytic leukemia is delayed contributing to early hemorrhagic death.
Altman JK; Rademaker A; Cull E; Weitner BB; Ofran Y; Rosenblat TL; Haidau A; Park JH; Ram SL; Orsini JM; Sandhu S; Catchatourian R; Trifilio SM; Adel NG; Frankfurt O; Stein EM; Mallios G; Deblasio T; Jurcic JG; Nimer S; Peterson LC; Kwaan HC; Rowe JM; Douer D; Tallman MS
Leuk Res; 2013 Sep; 37(9):1004-9. PubMed ID: 23768930
[TBL] [Abstract][Full Text] [Related]
19. Factors affecting thrombohemorrhagic early death in patients with acute promyelocytic leukemia treated with arsenic trioxide alone.
Hou W; Zhang Y; Jin B; Cao W; Lu M; Yan L; Yang H; Tian X; Hou J; Fu J; Zhao H; Li H; Zhou J
Blood Cells Mol Dis; 2019 Nov; 79():102351. PubMed ID: 31400712
[TBL] [Abstract][Full Text] [Related]
20. The experience of the International Consortium on Acute Promyelocytic Leukemia in monitoring minimal residual disease in acute promyelocytic leukaemia.
Lange AP; Lima AS; Lucena-Araujo AR; Jácomo RH; Melo RA; Bittencourt RI; Pasquini R; Pagnano K; Fagundes EM; Chauffaille ML; Chiattone CS; Sanz MA; Lo-Coco F; Grimwade D; Rego EM
Br J Haematol; 2018 Mar; 180(6):915-918. PubMed ID: 28025822
[No Abstract] [Full Text] [Related]
[Next] [New Search]
